Dermatology Clinical Trials
Like all fields of medicine, dermatology is an ever-evolving science. Advancements in research are made every day, allowing doctors to offer new treatments and medications to patients that will provide the best possible outcomes.
Innovations in Patient Treatment
Clinical research trials serve as the avenue to allow these treatments and medications to eventually reach the public. Clinical trials involve human volunteer patients, allowing them to receive investigational treatments- a new drug or device. Trials are closely monitored by specialized physicians and are the primary way researchers can evaluate safety, efficacy, benefits and effectiveness of new treatments.
Dr. Yadav is proud to be at the forefront of dermatological research. In partnership with Centricity Research, one of the most highly regarded and renowned clinical research organizations across Canada and the United States, Dr. Yadav can offer patients the opportunity to participate in trials that have the newest and most advanced investigational treatments in dermatology.
If you are interested in contributing to medical advancements by participating in one of our clinical studies, you are encouraged to discuss the opportunity with Dr. Yadav or our clinical staff. Please fill out your contact information below.
Clinical Trials Conducted at FACET Dermatology
Pruritus (itch) of unknown origin: Two randomized double blind, placebo controlled, multi-center, parallel group studies to evaluate the efficacy and safety of dupliumab in adult patients with chronic pruritus of unknown origin.
Urticaria (Hives): A randomized, double-blind, placebo-controlled, multi-center, dose ranging Phase 2 study of rilzabrutinib followed by an open-label extension phase in patients with moderate-to-severe chronic spontaneous urticaria (CSU) antihistamine treatment.
Atopic Dermatitis (Eczema): A study to assess real-world use, safety, and effectiveness of oral upadacitinib in adult and adolescent (>=12 Years Old) participants with atopic dermatitis (AD-VISE),
Psoriasis: A Canadian real world evidence study of brodalumab in plaque psoriasis to understand the impact on quality of life and work productivity.
Hand Dermatitis (Hand Eczema): A 24- week, randomised, assessor-blinded, active- controlled, parallel-group, phase 3, 2-arm trial to compare the efficacy.
Atopic Dermatitis-Vaccine Response Clinical Research Trial (40 Weeks): Recruiting adults with a diagnosis of atopic dermatitis (AD) that has been present for at least 6 months, to participate in this clinical research trial.